186 related articles for article (PubMed ID: 38608123)
1. The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract][Full Text] [Related]
2. Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Horm Cancer; 2012 Aug; 3(4):147-59. PubMed ID: 22476979
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive bioinformatics analysis reveals the significance of forkhead box family members in pancreatic adenocarcinoma.
Hu W; Li M; Wang Y; Zhong C; Si X; Shi X; Wang Z
Aging (Albany NY); 2023 Jan; 15(1):92-107. PubMed ID: 36622275
[TBL] [Abstract][Full Text] [Related]
4. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
6. FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer.
Wolf I; Bose S; Williamson EA; Miller CW; Karlan BY; Koeffler HP
Int J Cancer; 2007 Mar; 120(5):1013-22. PubMed ID: 17163418
[TBL] [Abstract][Full Text] [Related]
7. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.
Shigekawa T; Ijichi N; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Horm Cancer; 2011 Oct; 2(5):286-97. PubMed ID: 21901488
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
[TBL] [Abstract][Full Text] [Related]
9. Roles and correlation of FOXA1 and ZIC1 in breast cancer.
Zhang YW; Ma J; Shi CT; Han W; Gao XJ; Zhou MH; Ding HZ; Wang HN
Curr Probl Cancer; 2020 Oct; 44(5):100559. PubMed ID: 32115254
[TBL] [Abstract][Full Text] [Related]
10. Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Milevskiy MJ; Al-Ejeh F; Saunus JM; Northwood KS; Bailey PJ; Betts JA; McCart Reed AE; Nephew KP; Stone A; Gee JM; Dowhan DH; Dray E; Shewan AM; French JD; Edwards SL; Clark SJ; Lakhani SR; Brown MA
Hum Mol Genet; 2016 Aug; 25(15):3269-3283. PubMed ID: 27378691
[TBL] [Abstract][Full Text] [Related]
11. High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer.
Horimoto Y; Sasahara N; Sasaki R; Hlaing MT; Sakaguchi A; Saeki H; Arakawa A; Himuro T; Saito M
Breast Cancer Res Treat; 2020 Aug; 183(1):41-48. PubMed ID: 32572714
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 and estrogen signaling in breast cancer.
Ijichi N; Ikeda K; Horie-Inoue K; Inoue S
Vitam Horm; 2013; 93():203-12. PubMed ID: 23810008
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer.
Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Takahashi S; Homma Y; Urano T; Aburatani H; Inoue S
Mol Endocrinol; 2014 Dec; 28(12):2012-24. PubMed ID: 25329375
[TBL] [Abstract][Full Text] [Related]
14. Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer.
BenAyed-Guerfali D; Dabbèche-Bouricha E; Ayadi W; Trifa F; Charfi S; Khabir A; Sellami-Boudawara T; Mokdad-Gargouri R
Mol Biol Rep; 2019 Jun; 46(3):3247-3255. PubMed ID: 30941644
[TBL] [Abstract][Full Text] [Related]
15. Human FOX gene family (Review).
Katoh M; Katoh M
Int J Oncol; 2004 Nov; 25(5):1495-500. PubMed ID: 15492844
[TBL] [Abstract][Full Text] [Related]
16. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
Jing X; Liang H; Hao C; Hongxia L; Cui X
Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC
Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572
[TBL] [Abstract][Full Text] [Related]
18. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
19. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
20. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]